What does a urine microalbumin-to-creatinine ratio of 140 mg/g indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A Microalbumin/Creatinine Ratio of 140 mg/g Indicates Moderately Increased Albuminuria (Previously Called Microalbuminuria)

A urine microalbumin-to-creatinine ratio of 140 mg/g falls within the moderately increased albuminuria range (30-300 mg/g) and signals early kidney damage, significantly elevated cardiovascular risk, and requires immediate intervention with blood pressure optimization and consideration of ACE inhibitor or ARB therapy.

Understanding the Result

Your ratio of 140 mg/g places you in the moderately increased albuminuria category 1, 2. The established definitions are:

  • Normal: <30 mg/g creatinine
  • Moderately increased albuminuria: 30-300 mg/g creatinine
  • Severely increased albuminuria: ≥300 mg/g creatinine

This level represents early kidney damage and is not simply a benign finding 3, 4.

Clinical Significance

Kidney Disease Risk

At 140 mg/g, you have documented kidney injury that, without intervention, carries a 20-40% risk of progression to end-stage renal disease over time 3, 5. This is particularly true if you have diabetes or hypertension 4, 6.

Cardiovascular Risk

This finding is a well-established marker of greatly increased cardiovascular morbidity and mortality 3, 4, 6. The presence of moderately increased albuminuria indicates generalized endothelial dysfunction and atherosclerosis, not just kidney problems 7.

Confirmation Required

Before making treatment decisions, this result must be confirmed 1, 4. The guidelines are clear:

  • Repeat the test 2 more times within 3-6 months
  • You need 2 out of 3 elevated samples to confirm persistent albuminuria
  • Use first-morning spot collections when possible 1

Important Caveats

Several factors can cause transient elevations that don't represent true kidney disease 4:

  • Vigorous exercise within 24 hours (refrain before testing) 1
  • Urinary tract infection
  • Fever or acute illness
  • Marked hyperglycemia (if diabetic)
  • Uncontrolled hypertension
  • Congestive heart failure

Immediate Actions Required

1. Blood Pressure Control

Target blood pressure <130/80 mmHg 5, 7. This is non-negotiable for anyone with albuminuria, regardless of whether you have diabetes 7.

2. Medication Consideration

If you have diabetes with confirmed moderately increased albuminuria, either an ACE inhibitor or ARB is recommended 6, 8. These medications:

  • Reduce albuminuria by at least 30% in most patients
  • Slow progression to kidney failure
  • Reduce cardiovascular events 6

If you don't have diabetes but have hypertension with confirmed albuminuria, ACE inhibitors or ARBs are suggested 6. However, for primary prevention in patients with normal blood pressure and no diabetes, these medications are not recommended 6.

3. Glycemic Control (If Diabetic)

Target HbA1c <7% to delay progression 3, 5, 6. Intensive glucose management has been proven to slow albuminuria progression in both type 1 and type 2 diabetes 3, 6.

4. Lifestyle Modifications

  • Sodium restriction to <6 g/day 9
  • Weight reduction if BMI >30 7
  • Smoking cessation (mandatory) 9, 7
  • Moderate protein intake (0.8 g/kg/day based on ideal body weight) 6

Monitoring Strategy

Once confirmed and treatment initiated:

  • Retest UACR every 6 months to assess treatment response 1, 2
  • Goal: Reduce UACR by at least 30-50% from baseline, ideally achieving <30 mg/g 2, 10
  • Measure estimated GFR (eGFR) annually to assess kidney function 6, 8
  • If eGFR falls below 60 mL/min/1.73 m², consider nephrology referral 6, 8

Treatment Response Monitoring

A sustained reduction of >30% in your UACR is accepted as evidence of slowed kidney disease progression 2, 10. If your UACR doesn't decrease after 6 months of treatment:

  1. Verify blood pressure targets are met
  2. Confirm ACE inhibitor or ARB is at maximum tolerated dose
  3. Evaluate medication adherence
  4. Consider adding additional antihypertensive agents 1

Risk Stratification

With a UACR of 140 mg/g, you are in the moderate-to-high risk category for both cardiovascular events and CKD progression 2, 8. This risk increases substantially if you also have:

  • Diabetes
  • Hypertension
  • Reduced eGFR (<60 mL/min/1.73 m²)
  • Family history of kidney disease

The combination of moderately increased albuminuria with any reduction in eGFR moves you into the highest risk category requiring aggressive intervention 2, 8.

Related Questions

Should I start with a 5 mg or 10 mg daily dose for a urine albumin‑to‑creatinine ratio of 328 mg/g?
In a patient with urine microalbumin >300 mg (unreadable) and estimated glomerular filtration rate 90 mL/min, what is the significance and recommended management?
What does a urine microalbumin of 2,493 µg/mL and an albumin‑to‑creatinine ratio of 1,529 µg/mg indicate, and what is the appropriate management?
What does a urine microalbumin-to-creatinine ratio of 1055 mg/g indicate and how should it be managed?
In a 44-year-old female with bipolar disorder who has taken naproxen for several days and now has a serum creatinine of 1.06 mg/dL and a urine microalbumin-to-creatinine ratio of 186 mg/g, what management steps should be taken?
I have chest pressure and left‑arm pain radiating down the arm; the emergency‑department electrocardiogram showed ST‑segment changes suggestive of acute ST‑segment elevation myocardial infarction (STEMI), but the physician said it was normal due to recent exercise—what is the likely cause and how should I be evaluated?
What vital sign values are considered abnormal in a toddler (aged 1‑3 years)?
While I am still in the emergency department experiencing chest pressure and left‑arm pain, what actions should I take and what should I request from the staff?
What is the appropriate intravenous empirical dosing regimen of tigecycline for a patient with perforated peritonitis?
What are the recommended treatment guidelines for cellulitis of the chin?
What loading dose does the Infectious Diseases Society of America (IDSA) 2026 edition recommend for tigecycline?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.